Targeting spinal mechanistic target of rapamycin complex 2 alleviates inflammatory and neuropathic pain - Summary - MDSpire

Targeting spinal mechanistic target of rapamycin complex 2 alleviates inflammatory and neuropathic pain

  • By

  • Calvin Wong

  • Luis David Rodriguez-Hernandez

  • Kevin C Lister

  • Ning Gu

  • Weihua Cai

  • Mehdi Hooshmandi

  • Jonathan Fan

  • Nicole Brown

  • Vivienne Nguyen

  • Alfredo Ribeiro-da-Silva

  • Robert P Bonin

  • Arkady Khoutorsky

  • August 21, 2024

  • 0 min

Share

Objective:

To investigate the role of spinal mTORC2 in the development and maintenance of inflammatory and neuropathic pain, highlighting its potential as a therapeutic target.

Key Findings:
  • Pharmacological activation of mTORC2 induces long-lasting mechanical and thermal hypersensitivity, suggesting a critical role in pain pathways.
  • Inhibition of mTORC2 alleviates inflammatory and neuropathic pain symptoms, indicating its potential as a therapeutic target.
  • Cell type-specific functions of mTORC2 were identified in mediating pain hypersensitivity, highlighting the need for targeted therapies.
Interpretation:

Spinal mTORC2 plays a critical role in chronic pain mechanisms, with distinct functions in different neuronal populations, suggesting avenues for targeted therapeutic interventions.

Limitations:
  • Study primarily conducted in animal models; human applicability remains to be established, necessitating further research.
  • Potential off-target effects of pharmacological agents not fully explored, which could impact the interpretation of results.
Conclusion:

Targeting spinal mTORC2 may provide a novel therapeutic approach for managing chronic pain conditions, warranting further investigation into specific treatment strategies.

Original Source(s)

Related Content